Ambu Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Ambu şirketinin toplam hissedar öz sermayesi DKK5.6B ve toplam borcu DKK0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla DKK7.2B ve DKK1.6B dir. Ambu 'in FAVÖK'ü DKK645.0M faiz karşılama oranı 53.8 dur. Şirketin DKK615.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

DKK 0

Borç

Faiz karşılama oranı	53.8x
Nakit	DKK 615.00m
Eşitlik	DKK 5.59b
Toplam yükümlülükler	DKK 1.56b
Toplam varlıklar	DKK 7.15b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AMBUBC 'nin kısa vadeli varlıkları ( DKK2.6B ) kısa vadeli yükümlülüklerini ( DKK1.1B ) aşıyor.

Uzun Vadeli Yükümlülükler: AMBUBC şirketinin kısa vadeli varlıkları ( DKK2.6B ) uzun vadeli yükümlülüklerini ( DKK501.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AMBUBC borçsuzdur.

Borcun Azaltılması: AMBUBC şirketinin 5 yıl önce borç/öz sermaye oranı 48.7% iken borcu yok.

Borç Kapsamı: AMBUBC un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: AMBUBC şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Ambu Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Ambu A/S Proposes Dividend

Ambu A/S, Annual General Meeting, Dec 03, 2025

Ambu A/S to Report Q1, 2025 Results on Jan 30, 2025

Second quarter 2024 earnings released: EPS: kr.0.54 (vs kr.0.06 in 2Q 2023)

First quarter 2024 earnings released: EPS: kr.0.35 (vs kr.0.09 in 1Q 2023)

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

High number of new directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

High number of new directors

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

High number of new directors

Second quarter 2023 earnings released

High number of new directors

High number of new directors

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

High number of new directors

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings released

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Less than half of directors are independent

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Less than half of directors are independent

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Less than half of directors are independent

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

Second quarter 2022 earnings released

Less than half of directors are independent

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Ambu A/S Revises Revenue Guidance for the Fiscal 2022

Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit

Upcoming dividend of kr.0.29 per share

Full year 2021 earnings released: EPS kr.0.98 (vs kr.0.98 in FY 2020)

Third quarter 2021 earnings released

Less than half of directors are independent

Ambu A/S Revises Revenue Guidance for the Fiscal 2021

Second quarter 2021 earnings released

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021

New 90-day high: kr.331

Ambu A/S has completed a Follow-on Equity Offering in the amount of DKK 1.2345 billion.

Revenue beats expectations

New 90-day high: kr.310

First quarter 2021 earnings released

Ambu A/S to Report Fiscal Year 2021 Results on Nov 09, 2021

New 90-day high: kr.263

New 90-day high: kr.212

Upcoming Dividend of kr.0.29 Per Share

Ambu A/S Announces Board Changes

Ambu A/S to Report Q2, 2021 Results on May 12, 2021

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin